SOURCE: Solos Endoscopy, Inc.

February 06, 2007 08:31 ET

Solos Endoscopy, Inc. Expands Surgical Instrument Line by Signing Manufacturing Agreement With Tekno-Medical

BOSTON, MA -- (MARKET WIRE) -- February 6, 2007 -- Solos Endoscopy, Inc. (PINKSHEETS: SLSY) is pleased to announce that it has signed a manufacturing agreement with Tekno-Medical of Germany. The agreement will allow Solos Endoscopy to expand its surgical instrument line and to develop and market new instrument styles. The agreement evolved during the combined development of proprietary products by the two companies.

Tekno-Medical, a leading surgical instrument company, was founded in 1976 and specializes in surgical, endoscopic, and dental instruments, as well as other medical supplies. Tekno-Medical has become a major manufacturer of more than 8,000 different instruments for all major surgical disciplines. Tekno-Medical's instruments are produced using the latest technology and German forgings by skilled craftsmen in accordance to the very highest industry standards.

"This agreement provides us with an innovative approach to manufacturing and additional research capabilities to further develop state-of-the-art surgical instrumentation. We have worked with Tekno-Medical for over 15 years and stand to benefit significantly from this partnership," stated Bob Segersten, President of Solos Endoscopy, Inc.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office.

Additional information is available on the Company's website at:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Information

  • Contact:
    Solos Endoscopy, Inc.
    Investor Relations